EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Short-term costs and cost-efficiency of HPV triage strategies in a high HIV-prevalence setting: Evidence from Botswana

Adriane Wynn iD, Devon Harris, Anna Modest iD, Maria de Fatima Reyes iD, Bridgette Wamakima, Kelebogile Gaborone, Natasha Moraka iD, Annika Gompers, Sikhulile Moyo, Roger Shapiro, Doreen Ramogola-Masire, Rebecca Luckett

PLOS One · 2025

DOI: 10.1371/journal.pone.0328803 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Adriane Wynn und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases and Global Public Health, University of California San Diego, La Jolla, California, United States of America. Hauptthemen laut MEDLINE: HIV Infections, Triage, Papillomavirus Infections, Uterine Cervical Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIDDK NIH HHS, National Institute on Alcohol Abuse and Alcoholism.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cervical cancer remains the leading cause of cancer death among women in sub-Saharan Africa and is more severe in high HIV-burdened countries due to persistent high-risk human papillomavirus (hrHPV). In 2021, the World Health Organization recommended primary hrHPV testing for cervical cancer screening; however, optimal triage strategies following positive hrHPV tests remain unclear. We conducted a prospective cost analysis of triage methods for positive hrHPV results among women living with and without HIV in Gaborone, Botswana. We used a micro-costing approach from the perspective of the healthcare provider. The main outcomes were the implementation costs associated with three triage strategies following hrHPV testing: 8-type HPV genotype restriction, visual inspection with acetic acid (VIA), and colposcopy. We also compared the strategies by measuring the change in costs divided by the change in number of true cases of cervical intraepithelial neoplasia (CIN) 2 or worse (CIN2+) identified, based on the results of a prospective cohort study. Results indicated that the 8-type HPV genotype restriction strategy was the most cost-efficient, requiring no additional costs beyond hrHPV testing and identifying the highest number of true CIN2 + cases. VIA and colposcopy triage identified fewer true cases of CIN2+ and incurred additional costs, with colposcopy being the most expensive. Results were consistent in women with and without HIV. Sensitivity analysis highlighted personnel and hrHPV test kit cartridge costs as significant drivers of overall costs. Post-hoc analysis incorporating average treatment costs for precancer demonstrated that genotyping remained dominant at lower treatment costs but became less favorable as treatment costs increased. We found that 8-type genotype restriction was optimal compared to hrHPV screening combined with VIA or colposcopy. Cost estimates can inform future studies that examine the long-term costs and health outcomes of HPV-based two-stage screening algorithms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV InfectionsTriagePapillomavirus InfectionsUterine Cervical NeoplasmsUterine Cervical DysplasiaHumansFemaleBotswanaAdultCost-Benefit AnalysisProspective StudiesPrevalenceEarly Detection of CancerMiddle AgedPapillomaviridaeColposcopyGenotype

Autor:innen und Institutionen

  • Division of Infectious Diseases and Global Public Health, University of California San Diego, La Jolla, California, United States of America.
  • Botswana Harvard Health Partnership, Gaborone, Botswana.
  • Department of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States of America.
  • Department of Obstetrics and Gynecology at Brigham and Women's Hospital, Boston, United States of America.
  • Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, United States of America.
  • Department of Pathology, Division of Medical Virology, Stellenbosch University, Cape Town, South Africa.

ORCID-Profile: Adriane Wynn, Anna Modest, Maria de Fatima Reyes, Natasha Moraka

Förderung

  • NIAID NIH HHS
  • NIDDK NIH HHS
  • National Institute on Alcohol Abuse and Alcoholism
  • National Cancer Institute
  • Fogarty International Center

Zitieren

APA

Wynn, A., Harris, D., Modest, A., Reyes, M. F., Wamakima, B., Gaborone, K., Moraka, N., Gompers, A., Moyo, S., Shapiro, R., Ramogola-Masire, D., & Luckett, R. (2025). Short-term costs and cost-efficiency of HPV triage strategies in a high HIV-prevalence setting: Evidence from Botswana. PLOS One. https://doi.org/10.1371/journal.pone.0328803

Vancouver

Wynn A, Harris D, Modest A, Reyes MF, Wamakima B, Gaborone K, et al. Short-term costs and cost-efficiency of HPV triage strategies in a high HIV-prevalence setting: Evidence from Botswana. PLOS One. 2025. doi:10.1371/journal.pone.0328803

BibTeX
@article{Wynn2025,
  author = {Wynn, Adriane and Harris, Devon and Modest, Anna and Reyes, Maria de Fatima and Wamakima, Bridgette and Gaborone, Kelebogile and Moraka, Natasha and Gompers, Annika and Moyo, Sikhulile and Shapiro, Roger and Ramogola-Masire, Doreen and Luckett, Rebecca},
  title = {Short-term costs and cost-efficiency of HPV triage strategies in a high HIV-prevalence setting: Evidence from Botswana},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0328803}
}
Kostenlos starten →